+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Acute Ischemic Stroke Therapeutics Market 2020-2024

  • ID: 5212588
  • Report
  • November 2020
  • Region: Global
  • 120 Pages
  • TechNavio
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

FEATURED COMPANIES

  • Amgen Inc.
  • AstraZeneca Plc
  • Bayer AG
  • Bristol-Myers Squibb Co.
  • Daiichi Sankyo Co. Ltd.
  • F. Hoffmann-La Roche Ltd.
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Global Acute Ischemic Stroke Therapeutics Market 2020-2024

The publisher has been monitoring the acute ischemic stroke therapeutics market and it is poised to grow by $ 1.22 bn during 2020-2024, progressing at a CAGR of 5% during the forecast period. The reports on the acute ischemic stroke therapeutics market provide a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the rising prevalence of stroke, increasing adoption of NOACs, and increasing prevalence of sedentary lifestyles. In addition, the rising prevalence of stroke is anticipated to boost the growth of the market as well.

The acute ischemic stroke therapeutics market analysis includes type segment and geographical landscapes.

The acute ischemic stroke therapeutics market is segmented as below:

By Type
  • Thrombolytics
  • Anticoagulants
  • Antiplatelets
  • Antihypertensives
  • Other therapeutics

By Geographical Landscapes
  • North America
  • Europe
  • Asia
  • ROW

This study identifies the TBI, a value-addition in AIS research as one of the prime reasons driving the acute ischemic stroke therapeutics market growth during the next few years. Also, the advent of genomic medicine and a strong pipeline will lead to sizable demand in the market.

The acute ischemic stroke therapeutics market report covers the following areas:
  • Acute ischemic stroke therapeutics market sizing
  • Acute ischemic stroke therapeutics market forecast
  • Acute ischemic stroke therapeutics market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading acute ischemic stroke therapeutics market vendors that include Amgen Inc., AstraZeneca Plc, Bayer AG, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Co., Daiichi Sankyo Co. Ltd., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Pfizer Inc., and Sanofi. Also, the acute ischemic stroke therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Amgen Inc.
  • AstraZeneca Plc
  • Bayer AG
  • Bristol-Myers Squibb Co.
  • Daiichi Sankyo Co. Ltd.
  • F. Hoffmann-La Roche Ltd.

Executive Summary
  • Market Overview

Market Landscape
  • Market ecosystem
  • Market characteristics
  • Value chain analysis

Market Sizing
  • Market definition
  • Market segment analysis
  • Market size 2019
  • Market outlook: Forecast for 2019 - 2024

Five Forces Analysis
  • Five forces summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by Type
  • Market segments
  • Comparison by Type
  • Thrombolytics - Market size and forecast 2019-2024
  • Anticoagulants - Market size and forecast 2019-2024
  • Antiplatelets - Market size and forecast 2019-2024
  • Antihypertensives - Market size and forecast 2019-2024
  • Other therapeutics - Market size and forecast 2019-2024
  • Market opportunity by Type

Customer landscape
  • Customer landscape

Geographic Landscape
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • Asia - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity by geography
  • Market drivers
  • Market challenges
  • Market trends

Vendor Landscape
  • Vendor landscape
  • Landscape disruption
  • Competitive Scenario

Vendor Analysis
  • Vendors covered
  • Market positioning of vendors
  • Amgen Inc.
  • AstraZeneca Plc
  • Bayer AG
  • Boehringer Ingelheim International GmbH
  • Bristol-Myers Squibb Co.
  • Daiichi Sankyo Co. Ltd.
  • F. Hoffmann-La Roche Ltd.
  • Merck & Co. Inc.
  • Pfizer Inc.
  • Sanofi

Appendix
  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

List of Exhibit
  • Key Finding 1
  • Key Finding 2
  • Key Finding 3
  • Key Finding 5
  • Key Finding 6
  • Key Finding 7
  • Key Finding 8
  • Parent market
  • Market characteristics
  • Offerings of vendors included in the market definition
  • Market segments
  • Global - Market size and forecast 2019 - 2024 ($ million)
  • Global market: Year-over-year growth 2019 - 2024 (%)
  • Five forces analysis 2019 & 2024
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition - Five forces 2019
  • Type - Market share 2019-2024 (%)
  • Comparison by Type
  • Thrombolytics - Market size and forecast 2019-2024 ($ million)
  • Thrombolytics - Year-over-year growth 2019-2024 (%)
  • Anticoagulants - Market size and forecast 2019-2024 ($ million)
  • Anticoagulants - Year-over-year growth 2019-2024 (%)
  • Antiplatelets - Market size and forecast 2019-2024 ($ million)
  • Antiplatelets - Year-over-year growth 2019-2024 (%)
  • Antihypertensives - Market size and forecast 2019-2024 ($ million)
  • Antihypertensives - Year-over-year growth 2019-2024 (%)
  • Other therapeutics - Market size and forecast 2019-2024 ($ million)
  • Other therapeutics - Year-over-year growth 2019-2024 (%)
  • Market opportunity by Type
  • Customer landscape
  • Market share by geography 2019-2024 (%)
  • Geographic comparison
  • North America - Market size and forecast 2019-2024 ($ million)
  • North America - Year-over-year growth 2019-2024 (%)
  • Europe - Market size and forecast 2019-2024 ($ million)
  • Europe - Year-over-year growth 2019-2024 (%)
  • Asia - Market size and forecast 2019-2024 ($ million)
  • Asia - Year-over-year growth 2019-2024 (%)
  • ROW - Market size and forecast 2019-2024 ($ million)
  • ROW - Year-over-year growth 2019-2024 (%)
  • Key leading countries
  • Market opportunity by geography ($ million)
  • Impact of drivers and challenges
  • Vendor landscape
  • Landscape disruption
  • Industry risks
  • Vendors covered
  • Market positioning of vendors
  • Amgen Inc. - Overview
  • Amgen Inc. - Business segments
  • Amgen Inc. - Key offerings
  • Amgen Inc. - Key customers
  • Amgen Inc. - Segment focus
  • AstraZeneca Plc - Overview
  • AstraZeneca Plc - Product and service
  • AstraZeneca Plc - Key offerings
  • AstraZeneca Plc - Key customers
  • AstraZeneca Plc - Segment focus
  • Bayer AG - Overview
  • Bayer AG - Business segments
  • Bayer AG - Key offerings
  • Bayer AG - Key customers
  • Bayer AG - Segment focus
  • Boehringer Ingelheim International GmbH - Overview
  • Boehringer Ingelheim International GmbH - Business segments
  • Boehringer Ingelheim International GmbH - Key offerings
  • Boehringer Ingelheim International GmbH - Key customers
  • Boehringer Ingelheim International GmbH - Segment focus
  • Bristol-Myers Squibb Co. - Overview
  • Bristol-Myers Squibb Co. - Product and service
  • Bristol-Myers Squibb Co. - Key offerings
  • Bristol-Myers Squibb Co. - Key customers
  • Bristol-Myers Squibb Co. - Segment focus
  • Daiichi Sankyo Co. Ltd. - Overview
  • Daiichi Sankyo Co. Ltd. - Business segments
  • Daiichi Sankyo Co. Ltd. - Key offerings
  • Daiichi Sankyo Co. Ltd. - Key customers
  • Daiichi Sankyo Co. Ltd. - Segment focus
  • F. Hoffmann-La Roche Ltd. - Overview
  • F. Hoffmann-La Roche Ltd. - Business segments
  • F. Hoffmann-La Roche Ltd. - Key offerings
  • F. Hoffmann-La Roche Ltd. - Key customers
  • F. Hoffmann-La Roche Ltd. - Segment focus
  • Merck & Co. Inc. - Overview
  • Merck & Co. Inc. - Business segments
  • Merck & Co. Inc. - Key offerings
  • Merck & Co. Inc. - Key customers
  • Merck & Co. Inc. - Segment focus
  • Pfizer Inc. - Overview
  • Pfizer Inc. - Business segments
  • Pfizer Inc. - Key offerings
  • Pfizer Inc. - Key customers
  • Pfizer Inc. - Segment focus
  • Sanofi - Overview
  • Sanofi - Business segments
  • Sanofi - Key offerings
  • Sanofi - Key customers
  • Sanofi - Segment focus
  • Currency conversion rates for US$
  • Research Methodology
  • Validation techniques employed for market sizing
  • Information sources
  • List of abbreviations
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Amgen Inc.
  • AstraZeneca Plc
  • Bayer AG
  • Bristol-Myers Squibb Co.
  • Daiichi Sankyo Co. Ltd.
  • F. Hoffmann-La Roche Ltd.
The publisher recognizes the following companies as the key players in the global acute ischemic stroke therapeutics market: Amgen Inc., AstraZeneca Plc, Bayer AG, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Co., Daiichi Sankyo Co. Ltd., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Pfizer Inc., and Sanofi.

Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is TBI, a value-addition in AIS research.'

According to the report, one of the major drivers for this market is the rising prevalence of stroke.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Amgen Inc.
  • AstraZeneca Plc
  • Bayer AG
  • Boehringer Ingelheim International GmbH
  • Bristol-Myers Squibb Co.
  • Daiichi Sankyo Co. Ltd.
  • F. Hoffmann-La Roche Ltd.
  • Merck & Co. Inc.
  • Pfizer Inc.
  • Sanofi
Note: Product cover images may vary from those shown